Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1908129
PUBLISHER: Grand View Research | PRODUCT CODE: 1908129
Pan-genomic And Multi-gene Panel Testing Market Size, Share & Trends Analysis Report By Test, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Pan-genomic And Multi-gene Panel Testing Market Summary
The global pan-genomic & multi-gene panel testing market size was estimated at USD 8.96 billion in 2024 and is projected to reach USD 23.19 billion by 2033, growing at a CAGR of 11.37% from 2025 to 2033, driven by driven by clinical adoption in oncology and precision medicine and increasing demand for comprehensive genetic insights, rising use of molecular profiling in treatment planning, and advancements in high-throughput sequencing technologies. Compared to traditional single-gene assays, multi-gene panels that often span dozens to hundreds of cancer-related genes provide deeper and more comprehensive molecular insights.
Clinically validated assays, such as FoundationOne CDx (approximately 324 genes) and MSK-IMPACT (468 genes), are now routinely used in CLIA-certified laboratories to identify actionable genomic alterations. This has improved therapeutic matching, enabling clinicians to identify rare but targetable variants through a single, comprehensive analysis, rather than relying on sequential, time-consuming individual tests. As a result, major cancer centers are incorporating multi-gene and pan-genomic testing into their oncology workflows. Real-world results demonstrate the quantifiable impact of this adoption. A November 2024 study from the American Society of Clinical Oncology (ASCO) found that 36% of patients who underwent pathologist-directed comprehensive genomic profiling (CGP) received a targeted therapy (TT) or immuno-oncology (IO) agent simply because of biomarker findings in their genomic profile.
Moreover, the one of the key factors propelling the growth of the pan-genomic and multi-gene panel testing market is the swift and ongoing decrease in sequencing costs. The National Human Genome Research Institute (NHGRI) reports that significant advancements in next-generation sequencing (NGS) technologies have enabled the cost of sequencing a human genome to decrease from nearly USD 100 million in 2001 to approximately USD 600 in 2024. Comprehensive multi-gene testing was once a specialized and expensive process, but thanks to this significant decrease, it is now a readily available and reasonably priced tool for both patients and diagnostic laboratories. As a result, hereditary cancer testing has shifted from being used primarily in specialized genetics centers to becoming a standard component of preventive care and oncology workflows.
The rising global prevalence of genetic disorders, both inherited and newly occurring, has become one of the strongest drivers of the pan-genomic and multi-gene panel testing market. An estimated 400 million people worldwide suffer from rare genetic disorders, and 3-5% of all newborns are impacted by congenital or inherited genetic conditions. Healthcare systems are quickly incorporating extensive multi-gene and pan-genomic testing into standard protocols for early diagnosis, carrier screening, therapeutic decision-making, and long-term disease management as the genetic basis of more diseases becomes more apparent. Adoption in oncology is being greatly increased by the growing recognition of hereditary cancer syndromes, such as Lynch syndrome, Li-Fraumeni syndrome, and BRCA-associated breast/ovarian cancer. With 5-10% of all cancers classified as hereditary, and BRCA1/2 mutations increasing breast cancer risk by up to 70% and ovarian cancer risk by up to 40%, the need for proactive and comprehensive genomic screening has never been more compelling.
In addition, the increasing complexity of genomic data, particularly from whole-genome and large multi-gene panel tests, poses a significant challenge because interpreting millions of variants necessitates extensive clinical genomics and bioinformatics expertise. Many laboratories struggle to find enough molecular geneticists, clinical geneticists, and bioinformaticians to handle the workload. According to a global adoption framework for NGS in oncology published in PMC, a shortage of well-trained personnel, such as clinical molecular geneticists and genomic analysts, impedes widespread implementation. Moreover, infrastructural gaps in sequencing and bioinformatics pipelines exacerbate the issue, making it difficult to maintain consistent quality across laboratories.
Global Pan-genomic And Multi-gene Panel Testing Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pan-genomic & multi-gene panel testing market report based on test, application, end-use, and region:
- Test Outlook (Revenue, USD Million, 2021 - 2033)
- Pan-Genomic / Whole Exome Based Panels
- Comprehensive Hereditary Disease Panels
- Oncology Multi-Gene Panels
- Pharmacogenomics (PGx) Panels
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Oncology
- Cardiology & Cardiomyopathy
- Neurology and Neurogenetics
- Rare & Undiagnosed Genetic Diseases
- Reproductive Carrier Screening
- Newborn & Pediatric Genomics
- End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospital-based Genetic Labs
- Independent Diagnostic Labs
- Specialty Genomic Centers
- Others
- Regional Outlook (USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Product Code: GVR-4-68040-830-3
Table of Contents
Chapter 1. Pan-Genomic & Multi-Gene Panel Testing Market: Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Test
- 1.1.1.2. Application Segment
- 1.1.1.3. End Use Segment
- 1.1.1. Segment Definitions
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.4.1. Objective - 1
- 1.4.2. Objective - 2
- 1.4.3. Objective - 3
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.10. List of Secondary Sources
- 1.11. List of Abbreviations
Chapter 2. Pan-Genomic & Multi-Gene Panel Testing Market: Executive Summary
- 2.1. Market Snapshot
- 2.2. Test
- 2.3. Application Snapshot
- 2.4. End Use Snapshot
- 2.5. Competitive Landscape Snapshot
Chapter 3. Pan-Genomic & Multi-Gene Panel Testing Market Variables, Trends, & Scope
- 3.1. Market Segmentation and Scope
- 3.2. Market Lineage Outlook
- 3.2.1. Parent Market Outlook
- 3.2.2. Related/Ancillary Market Outlook
- 3.3. Market Dynamics
- 3.4. Market Drivers Analysis
- 3.4.1. Clinical adoption in oncology and precision medicine
- 3.4.2. Falling sequencing costs & tech advances
- 3.4.3. Increasing burden of genetic disorders & rising
- 3.5. Market Restraint Analysis
- 3.5.1. Complexity of data interpretation & shortage of skilled genomic specialists
- 3.5.2. Regulatory challenges, compliance Burdens & lack of standardization
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
- 3.8. Pipeline Analysis
Chapter 4. Pan-Genomic & Multi-Gene Panel Testing Market: Test Estimates & Trend Analysis
- 4.1. Pan-Genomic & Multi-Gene Panel Testing Market: Test Movement Analysis
- 4.2. Pan-Genomic / Whole Exome Based Panels
- 4.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.3. Comprehensive Hereditary Disease Panels
- 4.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4. Oncology Multi-Gene Panels
- 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.5. Pharmacogenomics (PGx) Panels
- 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 5. Pan-Genomic & Multi-Gene Panel Testing Market: Application Estimates & Trend Analysis
- 5.1. Pan-Genomic & Multi-Gene Panel Testing Market: Application Movement Analysis
- 5.2. Oncology
- 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.3. Cardiology & Cardiomyopathy
- 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4. Neurology and Neurogenetics
- 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.5. Rare & Undiagnosed Genetic Diseases
- 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.6. Reproductive Carrier Screening
- 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.7. Newborn & Pediatric Genomics
- 5.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 6. Pan-Genomic & Multi-Gene Panel Testing Market: End Use Estimates & Trend Analysis
- 6.1. Pan-Genomic & Multi-Gene Panel Testing Market: End Use Movement Analysis
- 6.2. Hospital-based Genetic Labs
- 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.3. Independent Diagnostic Labs
- 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4. Specialty Genomic Centers
- 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Others
- 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Pan-Genomic & Multi-Gene Panel Testing Market: Regional Business Analysis
- 7.1. Regional Market Snapshot
- 7.2. North America
- 7.2.1. North America Pan-Genomic & Multi-Gene Panel Testing Market Estimates and Forecast, 2021 - 2033 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. U.S. Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.2.2.2. Key Country Dynamics
- 7.2.2.3. Regulatory Framework
- 7.2.2.4. Reimbursement Scenario
- 7.2.2.5. Competitive Scenario
- 7.2.3. Canada
- 7.2.3.1. Canada Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.2.3.2. Key Country Dynamics
- 7.2.3.3. Regulatory Framework
- 7.2.3.4. Reimbursement Scenario
- 7.2.3.5. Competitive Scenario
- 7.2.4. Mexico
- 7.2.4.1. Mexico Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.2.4.2. Key Country Dynamics
- 7.2.4.3. Regulatory Framework
- 7.2.4.4. Reimbursement Scenario
- 7.2.4.5. Competitive Scenario
- 7.3. Europe
- 7.3.1. Europe Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.3.2. UK
- 7.3.2.1. UK Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.3.2.2. Key Country Dynamics
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. Reimbursement Scenario
- 7.3.2.5. Competitive Scenario
- 7.3.3. Germany
- 7.3.3.1. Germany Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.3.3.2. Key Country Dynamics
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Reimbursement Scenario
- 7.3.3.5. Competitive Scenario
- 7.3.4. Spain
- 7.3.4.1. Spain Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.3.4.2. Key Country Dynamics
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. Reimbursement Scenario
- 7.3.4.5. Competitive Scenario
- 7.3.5. France
- 7.3.5.1. France Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.3.5.2. Key Country Dynamics
- 7.3.5.3. Regulatory Framework
- 7.3.5.4. Reimbursement Scenario
- 7.3.5.5. Competitive Scenario
- 7.3.6. Italy
- 7.3.6.1. Italy Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.3.6.2. Key Country Dynamics
- 7.3.6.3. Regulatory Framework
- 7.3.6.4. Reimbursement Scenario
- 7.3.6.5. Competitive Scenario
- 7.3.7. Denmark
- 7.3.7.1. Denmark Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.3.7.2. Key Country Dynamics
- 7.3.7.3. Regulatory Framework
- 7.3.7.4. Reimbursement Scenario
- 7.3.7.5. Competitive Scenario
- 7.3.8. Sweden
- 7.3.8.1. Sweden Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.3.8.2. Key Country Dynamics
- 7.3.8.3. Regulatory Framework
- 7.3.8.4. Reimbursement Scenario
- 7.3.8.5. Competitive Scenario
- 7.3.9. Norway
- 7.3.9.1. Norway Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.3.9.2. Key Country Dynamics
- 7.3.9.3. Regulatory Framework
- 7.3.9.4. Reimbursement Scenario
- 7.3.9.5. Competitive Scenario
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.4.2. Japan
- 7.4.2.1. Japan Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.4.2.2. Key Country Dynamics
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Reimbursement Scenario
- 7.4.2.5. Competitive Scenario
- 7.4.3. China
- 7.4.3.1. China Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.4.3.2. Key Country Dynamics
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Reimbursement Scenario
- 7.4.3.5. Competitive Scenario
- 7.4.4. India
- 7.4.4.1. India Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.4.4.2. Key Country Dynamics
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. Reimbursement Scenario
- 7.4.4.5. Competitive Scenario
- 7.4.5. South Korea
- 7.4.5.1. South Korea Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.4.5.2. Key Country Dynamics
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Reimbursement Scenario
- 7.4.5.5. Competitive Scenario
- 7.4.6. Thailand
- 7.4.6.1. Thailand Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.4.6.2. Key Country Dynamics
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Reimbursement Scenario
- 7.4.6.5. Competitive Scenario
- 7.4.7. Australia
- 7.4.7.1. Australia Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.4.7.2. Key Country Dynamics
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. Reimbursement Scenario
- 7.4.7.5. Competitive Scenario
- 7.5. Latin America
- 7.5.1. Latin America Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Brazil Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.5.2.2. Key Country Dynamics
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement Scenario
- 7.5.2.5. Competitive Scenario
- 7.5.3. Argentina
- 7.5.3.1. Argentina Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.5.3.2. Key Country Dynamics
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement Scenario
- 7.5.3.5. Competitive Scenario
- 7.6. MEA
- 7.6.1. MEA Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. South Africa Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.6.2.2. Key Country Dynamics
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement Scenario
- 7.6.2.5. Competitive Scenario
- 7.6.3. Saudi Arabia
- 7.6.3.1. Saudi Arabia Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.6.3.2. Key Country Dynamics
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement Scenario
- 7.6.3.5. Competitive Scenario
- 7.6.4. UAE
- 7.6.4.1. UAE Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.6.4.2. Key Country Dynamics
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement Scenario
- 7.6.4.5. Competitive Scenario
- 7.6.5. Kuwait
- 7.6.5.1. Kuwait Pan-Genomic & Multi-Gene Panel Testing Market, 2021 - 2033 (USD Million)
- 7.6.5.2. Key Country Dynamics
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement Scenario
- 7.6.5.5. Competitive Scenario
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.2.1. New Product Launch
- 8.2.2. Partnerships
- 8.2.3. Acquisition
- 8.2.4. Collaboration
- 8.2.5. Funding
- 8.3. Key Company Market Share Analysis, 2024
- 8.4. Company Heat Map Analysis
- 8.5. Company Profiles
- 8.5.1. Illumina, Inc.
- 8.5.1.1. Company Overview
- 8.5.1.2. Financial Performance
- 8.5.1.3. Product Benchmarking
- 8.5.1.4. Strategic Initiatives
- 8.5.2. Thermo Fisher Scientific, Inc.
- 8.5.2.1. Company Overview
- 8.5.2.2. Financial Performance
- 8.5.2.3. Product Benchmarking
- 8.5.2.4. Strategic Initiatives
- 8.5.3. Fulgent Genetics
- 8.5.3.1. Company Overview
- 8.5.3.2. Financial Performance
- 8.5.3.3. Product Benchmarking
- 8.5.3.4. Strategic Initiatives
- 8.5.4. Ambry Genetics (Tempus)
- 8.5.4.1. Company Overview
- 8.5.4.2. Financial Performance
- 8.5.4.3. Product Benchmarking
- 8.5.4.4. Strategic Initiatives
- 8.5.5. GeneDx
- 8.5.5.1. Company Overview
- 8.5.5.2. Financial Performance
- 8.5.5.3. Product Benchmarking
- 8.5.5.4. Strategic Initiatives
- 8.5.6. Baylor Genetics
- 8.5.6.1. Company Overview
- 8.5.6.2. Financial Performance
- 8.5.6.3. Product Benchmarking
- 8.5.6.4. Strategic Initiatives
- 8.5.7. Natera
- 8.5.7.1. Company Overview
- 8.5.7.2. Financial Performance
- 8.5.7.3. Product Benchmarking
- 8.5.7.4. Strategic Initiatives
- 8.5.8. Caris Life Sciences
- 8.5.8.1. Company Overview
- 8.5.8.2. Financial Performance
- 8.5.8.3. Product Benchmarking
- 8.5.8.4. Strategic Initiatives
- 8.5.9. Foundation Medicine, Inc. (Roche)
- 8.5.9.1. Company Overview
- 8.5.9.2. Financial Performance
- 8.5.9.3. Product Benchmarking
- 8.5.9.4. Strategic Initiatives
- 8.5.10. Guardant Health
- 8.5.10.1. Company Overview
- 8.5.10.2. Financial Performance
- 8.5.10.3. Product Benchmarking
- 8.5.10.4. Strategic Initiatives
- 8.5.1. Illumina, Inc.
Product Code: GVR-4-68040-830-3
List of Tables
- Table 1 List Of Secondary Sources
- Table 2 List Of Abbreviation
- Table 3 Global Pan-Genomic & Multi-Gene Panel Testing Market, By Region, 2021 - 2033 (USD Million)
- Table 4 Global Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 5 Global Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 6 Global Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 7 North America Pan-Genomic & Multi-Gene Panel Testing Market, By Country, 2021 - 2033 (USD Million)
- Table 8 North America Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 9 North America Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 10 North America Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 11 U.S. Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 12 U.S. Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 13 U.S. Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 14 Canada Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 15 Canada Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 16 Canada Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 17 Mexico Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 18 Mexico Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 19 Mexico Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 20 Europe Pan-Genomic & Multi-Gene Panel Testing Market, By Country, 2021 - 2033 (USD Million)
- Table 21 Europe Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 22 Europe Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 23 Europe Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 24 UK Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 25 UK Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 26 UK Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 27 Germany Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 28 Germany Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 29 Germany Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 30 France Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 31 France Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 32 France Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 33 Italy Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 34 Italy Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 35 Italy Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 36 Spain Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 37 Spain Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 38 Spain Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 39 Sweden Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 40 Sweden Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 41 Sweden Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 42 Norway Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 43 Norway Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 44 Norway Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 45 Denmark Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 46 Denmark Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 47 Denmark Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 48 Asia Pacific Pan-Genomic & Multi-Gene Panel Testing Market, By Country, 2021 - 2033 (USD Million)
- Table 49 Asia Pacific Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 50 Asia-Pacific Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 51 Asia Pacific Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 52 Japan Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 53 Japan Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 54 Japan Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 55 China Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 56 China Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 57 China Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 58 India Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 59 India Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 60 India Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 61 Australia Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 62 Australia Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 63 Australia Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 64 Thailand Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 65 Thailand Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 66 Thailand Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 67 South Korea Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 68 South Korea Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 69 South Korea Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 70 Latin America Pan-Genomic & Multi-Gene Panel Testing Market, By Country, 2021 - 2033 (USD Million)
- Table 71 Latin America Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 72 Latin America Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 73 Latin America Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 74 Brazil Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 75 Brazil Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 76 Brazil Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 77 Argentina Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 78 Argentina Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 79 Argentina Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 80 MEA Pan-Genomic & Multi-Gene Panel Testing Market, By Country, 2021 - 2033 (USD Million)
- Table 81 MEA Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 82 MEA Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 83 MEA Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 84 South Africa Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 85 South Africa Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 86 South Africa Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 87 Saudi Arabia Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 88 Saudi Arabia Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 89 Saudi Arabia Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 90 UAE Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 91 UAE Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 92 UAE Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
- Table 93 Kuwait Pan-Genomic & Multi-Gene Panel Testing Market, By Test, 2021 - 2033 (USD Million)
- Table 94 Kuwait Pan-Genomic & Multi-Gene Panel Testing Market, By Application, 2021 - 2033 (USD Million)
- Table 95 Kuwait Pan-Genomic & Multi-Gene Panel Testing Market, By End Use, 2021 - 2033 (USD Million)
List of Figures
- Fig. 1 Pan-genomic & multi-gene panel testing market segmentation
- Fig. 2 Data analysis test technique
- Fig. 3 Market formulation and validation
- Fig. 4 Data validating & publishing
- Fig. 5 Market research process
- Fig. 6 Information procurement
- Fig. 7 Primary research
- Fig. 8 Value-chain-based sizing & forecasting
- Fig. 9 QFD biomarker modelling for market share assessment
- Fig. 10 Market formulation & validation
- Fig. 11 Commodity flow analysis
- Fig. 12 Market outlook
- Fig. 13 Segment snapshot-1
- Fig. 14 Segment snapshot-2
- Fig. 15 Competitive landscape snapshot
- Fig. 16 Market trends & outlook
- Fig. 17 Porter's five force analysis
- Fig. 18 PESTEL analysis
- Fig. 19 Pan-genomic & multi-gene panel testing market Test outlook key takeaways
- Fig. 20 Pan-genomic & multi-gene panel testing market: Test movement analysis
- Fig. 21 Pan-genomic / whole exome based panels market estimates, 2021 - 2033 (USD Million)
- Fig. 22 Comprehensive hereditary disease panels market estimates, 2021 - 2033 (USD Million)
- Fig. 23 Oncology multi-gene panels market estimates, 2021 - 2033 (USD Million)
- Fig. 24 Pharmacogenomics (PGx) panels market estimates, 2021 - 2033 (USD Million)
- Fig. 25 Pan-genomic & multi-gene panel testing market: Application outlook key takeaways
- Fig. 26 Pan-genomic & multi-gene panel testing market: Application movement analysis
- Fig. 27 Oncology market estimates, 2021 - 2033 (USD Million)
- Fig. 28 Cardiology & cardiomyopathy market estimates, 2021 - 2033 (USD Million)
- Fig. 29 Neurology and neurogenetics market estimates, 2021 - 2033 (USD Million)
- Fig. 30 Rare & undiagnosed genetic diseases market estimates, 2021 - 2033 (USD Million)
- Fig. 31 Reproductive carrier screening market estimates, 2021 - 2033 (USD Million)
- Fig. 32 Newborn & pediatric genomics market estimates, 2021 - 2033 (USD Million)
- Fig. 33 Pan-genomic & multi-gene panel testing market: End Use outlook key takeaways
- Fig. 34 Pan-genomic & multi-gene panel testing market: End Use movement analysis
- Fig. 35 Hospital-based genetic labs market estimates, 2021 - 2033 (USD Million)
- Fig. 36 Independent diagnostic labs market estimates, 2021 - 2033 (USD Million)
- Fig. 37 Specialty genomic centers market estimates, 2021 - 2033 (USD Million)
- Fig. 38 Others market estimates, 2021 - 2033 (USD Million)
- Fig. 39 Regional marketplace: Key takeaways
- Fig. 40 Middle East
- Fig. 41 Middle East market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 42 Saudi Arabia key country dynamics
- Fig. 43 Saudi Arabia market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 44 UAE key country dynamics
- Fig. 45 UAE market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 46 Kuwait key country dynamics
- Fig. 47 Kuwait market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 48 Oman key country dynamics
- Fig. 49 Oman market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 50 Qatar key country dynamics
- Fig. 51 Qatar market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 52 Rest of Middle East key country dynamics
- Fig. 53 Rest of Middle East market estimates and forecast, 2021 - 2033 (USD Million)
- Fig. 54 Market differentiators
- Fig. 55 Key company market share analysis
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.